Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Imatinib + MTX in Rheumatoid Arthritis
NCT00154336Phase 2Completed
- Sponsor
- Novartis
- Start
- Jul 2004
- Primary completion
- Aug 2005
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 2 trial of imatinib in rheumatoid arthritis (RA), sponsored by Novartis. Started Jul 2004; status: completed.
02
Drugs
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00154336.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00154336.